FOLFOX4 feasible first-line therapy for advanced gastric cancer

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen

By Vincenzi Bruno   Santini Daniele   Frezza Anna Maria   Berti Pierpaolo   Vespasiani Umberto   Picardi Antonio   Tonini Giuseppe  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 345-349

Informa Healthcare

Access to resources Recommend Favorite

Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 1066-1074

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Therapy of Antiandrogen and XIAP Inhibitor for Treating Advanced Prostate Cancer

By Danquah Michael  

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2079-2091

Springer Publishing Company

Access to resources Recommend Favorite